DK378687A - Laegemiddel, fremgangsmaade til dets fremstilling og anvendelse mod hiv-infektioner hos mennesker - Google Patents

Laegemiddel, fremgangsmaade til dets fremstilling og anvendelse mod hiv-infektioner hos mennesker

Info

Publication number
DK378687A
DK378687A DK378687A DK378687A DK378687A DK 378687 A DK378687 A DK 378687A DK 378687 A DK378687 A DK 378687A DK 378687 A DK378687 A DK 378687A DK 378687 A DK378687 A DK 378687A
Authority
DK
Denmark
Prior art keywords
medicine
procedure
manufacturing
against human
use against
Prior art date
Application number
DK378687A
Other languages
English (en)
Other versions
DK378687D0 (da
Inventor
Eckart Matthes
Christine Lehmann
Dieter Scholz
Martin Von Janta-Lipinski
Klaus Gaertner
Peter Langen
Hans-Alfred Rosenthal
Original Assignee
Akad Wissenschaften Ddr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27426554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK378687(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akad Wissenschaften Ddr filed Critical Akad Wissenschaften Ddr
Publication of DK378687D0 publication Critical patent/DK378687D0/da
Publication of DK378687A publication Critical patent/DK378687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK378687A 1986-07-24 1987-07-21 Laegemiddel, fremgangsmaade til dets fremstilling og anvendelse mod hiv-infektioner hos mennesker DK378687A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DD86292826A DD279407A1 (de) 1986-07-24 1986-07-24 Verfahren zur herstellung eines mittels gegen aids
DD30257387 1987-05-08
DD87303489A DD281346A5 (de) 1986-07-24 1987-06-03 Verfahren zur herstellung eines mittels gegen hiv-infektionen beim menschen
CA000571404A CA1333390C (en) 1986-07-24 1988-07-07 Fluorinated nucleosides and process for treating retrovirus infections therewith

Publications (2)

Publication Number Publication Date
DK378687D0 DK378687D0 (da) 1987-07-21
DK378687A true DK378687A (da) 1988-01-25

Family

ID=27426554

Family Applications (1)

Application Number Title Priority Date Filing Date
DK378687A DK378687A (da) 1986-07-24 1987-07-21 Laegemiddel, fremgangsmaade til dets fremstilling og anvendelse mod hiv-infektioner hos mennesker

Country Status (11)

Country Link
US (1) US4963662A (da)
EP (1) EP0254268B2 (da)
JP (1) JP2525418B2 (da)
AU (1) AU615431B2 (da)
CA (2) CA1333390C (da)
DD (2) DD279407A1 (da)
DE (1) DE3765045D1 (da)
DK (1) DK378687A (da)
ES (1) ES2036196T5 (da)
GR (1) GR3001214T3 (da)
NZ (1) NZ223836A (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US5446029A (en) * 1986-07-04 1995-08-29 Medivir Ab Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides
US5153180A (en) * 1986-07-24 1992-10-06 Eckart Matthes Fluorinated nucleosides and process for treating retrovirus infections therewith
EP0332626A1 (en) * 1986-11-21 1989-09-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions for treating viral infections in humans
US5495010A (en) * 1987-04-17 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services Acid stable purine dideoxynucleosides
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
JPS6468395A (en) * 1987-09-08 1989-03-14 Yamasa Shoyu Kk 3'-deoxyarbinofuranosylpyrimidine nucleoside derivative
EP0311107A3 (en) * 1987-10-08 1990-04-18 Stichting REGA V.Z.W. Anti-hiv active 3'-fluoro-purine-2',3'-dideoxyribosides
US5506215A (en) * 1987-11-03 1996-04-09 Medivir Ab 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
EP0316592A3 (en) * 1987-11-13 1990-09-19 Stichting REGA V.Z.W. 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
US4997926A (en) * 1987-11-18 1991-03-05 Scripps Clinic And Research Foundation Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
EP0355031A3 (de) * 1988-08-17 1990-12-27 MATTHES, Eckart, Dr. Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
WO1990003978A1 (en) * 1988-10-03 1990-04-19 Stichting Rega Vzw 5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application
WO1992006985A1 (en) * 1990-10-23 1992-04-30 City Of Hope Mechanism based inhibitors of dna methyltransferase
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
WO1991006554A1 (en) * 1989-11-06 1991-05-16 Nycomed As Nucleoside derivatives
GB9003543D0 (en) * 1990-02-16 1990-04-11 Wellcome Found Therapeutic nucleosides
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5180824A (en) * 1990-11-29 1993-01-19 Berlex Biosciences Inc. 6-azido-2-fluoropurine, useful in the synthesis of nucleosides
US5283331A (en) * 1990-12-20 1994-02-01 Nippon Kayaku Kabushiki Kaisha 2-halogeno-oxetanocin A and phosphoric ester thereof
DK0625158T3 (da) * 1992-01-06 1999-10-11 Wellcome Found Terapeutiske nucleosider af 2',3'-dideoxy-3'-fluorpurinrækken
WO1996011204A1 (de) * 1994-10-07 1996-04-18 Max-Delbrück-Centrum für Molekulare Medizin NEUE β-L-NUCLEOSIDE UND IHRE VERWENDUNG
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5728560A (en) * 1996-06-14 1998-03-17 Enzon, Inc. Method of treating CD4+ T cell lymphopenia in immuno-compromised patients
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
DE19720151A1 (de) * 1997-05-02 1998-11-05 Max Delbrueck Centrum Chimäre Oligonucleotide und ihre Verwendung
US20020128301A1 (en) * 1998-02-13 2002-09-12 Medivir AB Non-nucleoside reverse transcriptase inhibitors
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
WO2001060315A2 (en) * 2000-02-18 2001-08-23 Shire Biochem Inc. Method for the treatment or prevention of flavivirus infections using nucleoside analogues
WO2003000200A2 (en) * 2001-06-22 2003-01-03 Pharmasset Ltd. β-2'-OR 3'-HALONUCLEOSIDES
WO2003018030A1 (en) * 2001-08-24 2003-03-06 Koronis Pharmaceuticals, Inc. Mutagenic nucleoside analogs for the treatment of viral disease
PL217132B1 (pl) 2010-06-30 2014-06-30 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Modyfikowane 2',3'-dideoksynukleozydy do leczenia zakażeń szczepami ludzkiego wirusa nabytego niedoboru odporności (HIV) wykazującymi oporność wielolekową, sposób ich wytwarzania oraz farmaceutycznie dopuszczalna forma leku
AU2021237718B2 (en) 2020-03-20 2023-09-21 Gilead Sciences, Inc. Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE158903C (da) *
GB1189973A (en) * 1969-02-14 1970-04-29 Akad Wissenschaften Ddr Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
DD158903A1 (de) * 1981-05-18 1983-02-09 Gotthard Kowollik Verfahren zur herstellung von 3'-fluor-2',3'-didesoxyadenosin
DD209197A1 (de) * 1981-07-21 1984-04-25 Akad Wissenschaften Ddr Verfahren zur herstellung von 3'-fluor-2',3'-didesoxyguanosin
JPH02240622A (ja) * 1989-03-14 1990-09-25 Canon Inc 防振光学系

Also Published As

Publication number Publication date
ES2036196T5 (es) 1995-08-16
DK378687D0 (da) 1987-07-21
CA1333390C (en) 1994-12-06
EP0254268A2 (de) 1988-01-27
EP0254268B2 (de) 1994-01-12
EP0254268A3 (en) 1988-07-13
US4963662A (en) 1990-10-16
GR3001214T3 (en) 1992-07-30
DD279407A1 (de) 1990-06-06
AU615431B2 (en) 1991-10-03
DE3765045D1 (de) 1990-10-25
EP0254268B1 (de) 1990-09-19
JP2525418B2 (ja) 1996-08-21
AU1259288A (en) 1988-11-10
DD281346A5 (de) 1990-08-08
NZ223836A (en) 1990-12-21
CA1336820C (en) 1995-08-29
ES2036196T3 (es) 1993-05-16
JPS63107936A (ja) 1988-05-12

Similar Documents

Publication Publication Date Title
DK378687A (da) Laegemiddel, fremgangsmaade til dets fremstilling og anvendelse mod hiv-infektioner hos mennesker
DK159989A (da) Hudplejepraeparat, dets fremstilling og anvendelse
DK159689D0 (da) Medikeret hudplejepraeparat, dets fremstilling og anvendelse
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
DK223388D0 (da) Substrat, dets fremstilling og anvendelse
NO880434D0 (no) Anestetisk preparat og fremgangsmaate for bruk derav.
DK185187A (da) Lokkemad til snegle, dets fremstilling og anvendelse
DK39888A (da) Stabilt thrombinpraeparat, dets fremstilling og anvendelse
DK314686D0 (da) Laegemiddel, dets fremstilling og anvendelse mod indvoldsorme
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
DK381886A (da) Medicinsk praeparat og fremgangsmaade til dets fremstilling
DK261287A (da) Naphthyl-aromatiske forbindelser, deres fremstilling og deres anvendelse til human- og veterinaermedicinske og kosmetiske formaal
NO894532L (no) Titandioksyd, fremgangsmaate for dets fremstilling og anvendelse derav.
DK525687A (da) Enzymholdigt praeparat, dets fremstilling og anvendelse
DK424987D0 (da) Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling
DK125087D0 (da) Efomycin g., dets fremstilling og anvendelse
DK115389D0 (da) Applikator til hudrensemiddel, hudplejemiddel og medicinsk indgnidningsmiddel
DK587588D0 (da) Polypeptid, dets anvendelse og fremstilling
DK325186A (da) Anti-thrombosemiddel baseret paa glycosaminoglycan, fremgangsmaadetil dets fremstilling og farmaceutiske midler
DK80491A (da) Forbedrede polyoler, anvendelse og fremgangsmaade til fremstilling
DK420889D0 (da) Farmaceutisk kombinationspraeparat, dets fremstilling og anvendelse
NO870299D0 (no) Liposom/antrakinon-legemiddelpreparat og fremgangsmaate for dets fremstilling.
NO882136D0 (no) Transdermalt therapeutisk system, dets anvendelse og fremgangsmaate for dets fremstilling.
DK587688A (da) Polypeptid, dets anvendelse og fremstilling
DK395989D0 (da) Praeparat til konservering af mikrobielt fordaervelige produkter, dets fremstiling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn